Experienced in Venous Thromboembolism (VTE)

Dr. Maged Costantine

Neonatology
Osu Observation Medicine, LLC
452 W 10th Ave, 
Columbus, OH 
Experienced in Venous Thromboembolism (VTE)
Osu Observation Medicine, LLC
452 W 10th Ave, 
Columbus, OH 

Overview

Maged Costantine is a Neonatologist in Columbus, Ohio. Dr. Costantine is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Preeclampsia, High Blood Pressure in Infants, Gestational Diabetes, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

His clinical research consists of co-authoring 224 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Venous Thromboembolism (VTE).

Graduate Institution

American University Of Beirut, 2003

Residency

University Of Cincinnati Medical Center, Obstetrics & Gynecology, 2007

Specialties

Neonatology

Licenses

Obstetrics & Gynecology in TX

Board Certifications

American Board Of Obstetrics & Gynecology

Fellowships

University Of Texas Medical Branch-Galveston, 2010

Hospital Affiliations

Mercy Health - Springfield Regional Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
FirstCarolinaCare
  • HMO
  • MEDICARE MAPD
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

OSU OBSERVATION MEDICINE, LLC
452 W 10th Ave, Columbus, OH 43210
Other Locations
OSU OBSERVATION MEDICINE, LLC
1800 Zollinger Rd, Columbus, OH 43221

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

17 Clinical Trials

Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING): A Randomized Controlled Trial
Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING): A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: January 14, 2026
Intervention Type: Drug
Study Phase: Phase 4
NIH RECOVER: A Multi-site Observational Study of Post-acute Sequalae of SARS-CoV-2 Infection in Children
NIH RECOVER: A Multi-site Observational Study of Post-acute Sequalae of SARS-CoV-2 Infection in Children
Enrollment Status: Active_not_recruiting
Publish Date: December 31, 2025
A Randomized Controlled Trial of Pravastatin to Prevent Preeclampsia in High Risk Women
A Randomized Controlled Trial of Pravastatin to Prevent Preeclampsia in High Risk Women
Enrollment Status: Terminated
Publish Date: December 23, 2025
Intervention Type: Other, Drug
Study Drug: Pravastatin
Study Phase: Phase 3
NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
NIH RECOVER: A Multi-site Observational Study of Post-Acute Sequelae of SARS-CoV-2 Infection in Adults
Enrollment Status: Completed
Publish Date: December 15, 2025
A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
A Randomized Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Drug, Device
Study Phase: Phase 3
Non-invasive bioELEctroniC Treatment foR pOst-cesarean paiN (ELECTRON)
Non-invasive bioELEctroniC Treatment foR pOst-cesarean paiN (ELECTRON)
Enrollment Status: Completed
Publish Date: June 06, 2024
Intervention Type: Device
Study Phase: Not Applicable
Does a Repeat Course of Antenatal Corticosteroids in Pregnant Women With Preterm Premature Rupture of Membranes Decrease Neonatal Morbidity?
Does a Repeat Course of Antenatal Corticosteroids in Pregnant Women With Preterm Premature Rupture of Membranes Decrease Neonatal Morbidity?
Enrollment Status: Terminated
Publish Date: January 26, 2024
Intervention Type: Drug
Study Drug: Betamethasone
Study Phase: Phase 2/Phase 3
Frequency and Dosing of Long Acting Anti-Hypertensive Agent in Women With Pre-eclampsia With Severe Features Undergoing Expectant Management: A Randomized Controlled Trial
Frequency and Dosing of Long Acting Anti-Hypertensive Agent in Women With Pre-eclampsia With Severe Features Undergoing Expectant Management: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: December 22, 2023
Intervention Type: Drug
The HILIO Trial: High vs. Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity- PILOT STUDY
The HILIO Trial: High vs. Low Oxytocin Dosing for Induction of Labor in Pregnant Patients With Obesity- PILOT STUDY
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Drug
Study Phase: Phase 4
Relationship Between Plasma Concentration of (Hydroxyprogesterone Caproate) 17-OHPC and Preterm Birth
Relationship Between Plasma Concentration of (Hydroxyprogesterone Caproate) 17-OHPC and Preterm Birth
Enrollment Status: Terminated
Publish Date: October 23, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
Prescription After Cesarean Trial
Prescription After Cesarean Trial
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix
Enrollment Status: Terminated
Publish Date: June 22, 2023
Intervention Type: Device
Study Phase: Phase 3
A Randomized Controlled Trial of Treatment of Bacterial Vaginosis in Late Third Trimester to Prevent Maternal Peripartum Infection
A Randomized Controlled Trial of Treatment of Bacterial Vaginosis in Late Third Trimester to Prevent Maternal Peripartum Infection
Enrollment Status: Terminated
Publish Date: June 15, 2023
Intervention Type: Drug
Study Drug: Metronidazole
Study Phase: Phase 4
Maternal Morbidity and Mortality During the COVID-19 Pandemic
Maternal Morbidity and Mortality During the COVID-19 Pandemic
Enrollment Status: Completed
Publish Date: March 27, 2023
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial
Tranexamic Acid for the Prevention of Obstetrical Hemorrhage After Cesarean Delivery: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: February 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
Prospective, Single Arm Pivotal Clinical Trial Designed to Assess the Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
Prospective, Single Arm Pivotal Clinical Trial Designed to Assess the Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
Enrollment Status: Completed
Publish Date: August 22, 2022
Intervention Type: Device
Study Phase: Not Applicable
Pharmacokinetic and Pharmacogenomic Approach to Indomethacin Therapy in Pregnancy
Pharmacokinetic and Pharmacogenomic Approach to Indomethacin Therapy in Pregnancy
Enrollment Status: Completed
Publish Date: June 11, 2019
Intervention Type: Other
View 16 Less Clinical Trials

224 Total Publications

SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer.
SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody Transfer.
Journal: The Pediatric infectious disease journal
Published: November 17, 2025
Similar Doctors
Experienced in Venous Thromboembolism (VTE)
Dr. Philip Samuels
Neonatology | Obstetrics and Gynecology
Experienced in Venous Thromboembolism (VTE)
Dr. Philip Samuels
Neonatology | Obstetrics and Gynecology

Ohio State Outpatient Care Upper Arlington

1800 Zollinger Rd, 
Columbus, OH 
 (2.9 miles away)
614-293-2920
Languages Spoken:
English
See accepted insurances

Philip Samuels is a Neonatologist and an Obstetrics and Gynecologist in Columbus, Ohio. Dr. Samuels is rated as an Experienced provider by MediFind in the treatment of Venous Thromboembolism (VTE). His top areas of expertise are Preeclampsia, Premature Infant, Neonatal Sepsis, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).

Frequently Asked Questions about Dr. Maged Costantine

How do I make an appointment with Dr. Maged Costantine?

You can book an appointment with Dr. Maged Costantine by calling their office at 614-293-8487. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Maged Costantine a top-rated expert for Preeclampsia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Maged Costantine is classified as an Elite expert for Preeclampsia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Maged Costantine specialize in?

While Dr. Maged Costantine is a Neonatology, they have specific expertise in Preeclampsia, High Blood Pressure in Infants, and Gestational Diabetes. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neonatology.

Does Dr. Maged Costantine participate in research or clinical trials?

Yes. Dr. Maged Costantine has published 224 articles and abstracts on conditions like Preeclampsia. You can view a list of Dr. Maged Costantine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Maged Costantine accept my insurance?

Dr. Maged Costantine accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-293-8487 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Costantine's expertise for a condition
ConditionClose
    View All 26 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile